KEI asks FTC to block Celgene Acquisition of Juno​ Therapeutics, over BCMA-targeted CAR T treatment for Multiple Myeloma

On February 14, 2018, KEI meet with the FTC to express our opposition to Celgene’s proposed acquisition of Juno Therapeutics. Celgene-Juno-KEI-FTC16Feb2018 The Celgene acquisition of Juno Therapeutics would give Celgene control over competing candidates for the treatment of multiple myeloma… Continue Reading

Colombia

Blogs about compulsory licensing in Colombia are here.

2012-2013-nih-march-in-request-for-ritonavir

Pages on the 2012-2013 NIH Request November 1, 2013. NIH rejects March-In petition, also rejects proposed rules on pricing of and access to government funded inventions. October 15, 2013. 15 frequently asked questions about the 2012 ritonavir March-In petition October… Continue Reading

SCP 26

July 3 to July 6, 2017 WIPO’s Page for the Meeting SCP26 – Agreement reached on future work reached at WIPO Standing Committee on the Law of Patents (6 July 2017) WIPO SCP 26 KEI Side Event: Running royalties as… Continue Reading

WIPO’s proposed treaty on broadcasting

KEI’s timeline of WIPO negotiations on the treaty from 1961 to 2023 is available here. For SCCR 43, March 13 to March 17, 2023 Meeting documents. (link) English version of Second Revised Draft Text for the WIPO Broadcasting Organizations Treaty,prepared… Continue Reading

Orphan works (copyright and related rights)

KEI has advocated for copyright exceptions to expand access to works protected by copyright and related rights, when the owners of the rights cannot be located after reasonably diligent searches. Among the areas where KEI has be particularly active is… Continue Reading

Copyright exceptions

The evolution of exceptions in the Berne Convention: The Berne Convention revisions for limitations and exceptions to copyright, 2012:1 KEI Research Note Why do US and EU trade negotiators hate the Berne Copyright Limitations and Exceptions February 20, 2013. The… Continue Reading